Every SEC Form 3/4/5 on record for this filer (CIK 1529196) — 4 issuers, 139 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| GKOS | GLAUKOS Corp | Director | 2015-07-24 → 2026-06-23 | 19 | −$3M |
| RVNC | Revance Therapeutics, Inc. | President & CEO · Director | 2017-09-07 → 2025-02-06 | 35 | −$6M |
| SIBN | SI-BONE, Inc. | Director · lapsed | 2019-06-17 → 2020-06-18 | 3 | — |
| ZLTQ | Zeltiq Aesthetics Inc | President and CEO · Director · lapsed | 2015-07-14 → 2017-04-28 | 36 | −$15M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| GKOS | 2025-02-26 | Sell | 20,687 | $120.72 | $2M | 54,249 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.